378 related articles for article (PubMed ID: 29125235)
1. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
3. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
4. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
[TBL] [Abstract][Full Text] [Related]
5. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
6. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
7. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
[TBL] [Abstract][Full Text] [Related]
8. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
[TBL] [Abstract][Full Text] [Related]
9. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
[TBL] [Abstract][Full Text] [Related]
10. Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
Bashford-Rogers RJ; Palser AL; Hodkinson C; Baxter J; Follows GA; Vassiliou GS; Kellam P
Exp Hematol; 2017 Feb; 46():31-37.e10. PubMed ID: 27693386
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.
Stamatopoulos B; Haibe-Kains B; Equeter C; Meuleman N; Sorée A; De Bruyn C; Hanosset D; Bron D; Martiat P; Lagneaux L
Haematologica; 2009 Jun; 94(6):790-9. PubMed ID: 19377082
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
Till KJ; Pettitt AR; Slupsky JR
J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
[TBL] [Abstract][Full Text] [Related]
13. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.
Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A
J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
15. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
[TBL] [Abstract][Full Text] [Related]
16. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
[TBL] [Abstract][Full Text] [Related]
17. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.
Leveille E; Chan LN; Mirza AS; Kume K; Müschen M
Cell Signal; 2022 Jun; 94():110331. PubMed ID: 35398488
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
[TBL] [Abstract][Full Text] [Related]
20. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
